1. Phase II study of HCVIDD/MA in patients with newly diagnosed peripheral T‐cell lymphoma. (10th August 2015) Authors: Chihara, Dai; Pro, Barbara; Loghavi, Sanam; Miranda, Roberto N.; Medeiros, L. Jeffrey; Fanale, Michelle A.; Hagemeister, Fredrick B.; Fayad, Luis E.; Romaguera, Jorge E.; Samaniego, Felipe; Neelapu, Sattva S.; Younes, Anas; Fowler, Nathan H.; Rodriguez, M. Alma; Wang, Michael; Kwak, Larry W.; McL... Journal: British journal of haematology Issue: Volume 171:Number 4(2015:Nov.) Page Start: 509 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Responses to romidepsin by line of therapy in patients with relapsed or refractory peripheral T‐cell lymphoma. (16th December 2016) Authors: Foss, Francine; Pro, Barbara; Miles Prince, H.; Sokol, Lubomir; Caballero, Dolores; Horwitz, Steven; Coiffier, Bertrand Journal: Cancer medicine Issue: Volume 6:Number 1(2017:Jan.) Page Start: 36 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Long‐term overall‐ and progression‐free survival after pentostatin, cyclophosphamide and rituximab therapy for indolent non‐Hodgkin lymphoma. (28th February 2019) Authors: Khashab, Tamer; Hagemeister, Fredrick; Romaguera, Jorge E.; Fanale, Michelle A.; Pro, Barbara; McLaughlin, Peter; Rodriguez, M. Alma; Neelapu, Sattva S.; Fayad, Luis; Younes, Anas; Feng, Lei; Vega, Francisco; Kwak, Larry W.; Samaniego, Felipe Journal: British journal of haematology Issue: Volume 185:Number 4(2019) Page Start: 670 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. A prospective cohort study of patients with peripheral T‐cell lymphoma in the United States. Issue 7 (2nd December 2016) Authors: Carson, Kenneth R.; Horwitz, Steven M.; Pinter‐Brown, Lauren C.; Rosen, Steven T.; Pro, Barbara; Hsi, Eric D.; Federico, Massimo; Gisselbrecht, Christian; Schwartz, Marc; Bellm, Lisa A.; Acosta, Mark A.; Shustov, Andrei R.; Advani, Ranjana H.; Feldman, Tatyana A.; Lechowicz, Mary Jo; Smith, Sonal... Journal: Cancer Issue: Volume 123:Issue 7(2017) Page Start: 1174 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial. Issue 9 (September 2018) Authors: Kim, Youn H; Bagot, Martine; Pinter-Brown, Lauren; Rook, Alain H; Porcu, Pierluigi; Horwitz, Steven M; Whittaker, Sean; Tokura, Yoshiki; Vermeer, Maarten; Zinzani, Pier Luigi; Sokol, Lubomir; Morris, Stephen; Kim, Ellen J; Ortiz-Romero, Pablo L; Eradat, Herbert; Scarisbrick, Julia; Tsianakas, Ath... Journal: Lancet oncology Issue: Volume 19:Issue 9(2018) Page Start: 1192 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. PD1 regulates T cell exhaustion phenotypes and disease aggressiveness in CTCL. (October 2021) Authors: Daniels, Jay; Park, Joonhee; Wartewig, Tim; Martinez-Escala, Maria Estela; Pro, Barbara; Sosman, Jeffrey; Guitart, Joan; Rao, Deepak; Ruland, Jurgen; Choi, Jaehyuk Journal: European journal of cancer Issue: Volume 156(2021)Supplement 1 Page Start: S2 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Subtype-specific differences in the genomic landscape of cutaneous T cell lymphomas. (October 2021) Authors: Park, Joonhee; Daniels, Jay; Ringbloom, Kimberly; Martinez-Escala, Maria Estela; Yang, Jingyi; Snowden, Caroline; Zhang, Yancong; Mo, Samuel; Pro, Barbara; Sosman, Jeffrey; Guitart, Joan; Choi, Jaehyuk Journal: European journal of cancer Issue: Volume 156(2021)Supplement 1 Page Start: S2 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. A phase I/II trial of brentuximab vedotin plus rituximab as frontline therapy for patients with immunosuppression-associated CD30+ and/or EBV + lymphomas. Issue 14 (6th December 2021) Authors: Pearse, William B.; Petrich, Adam M.; Gordon, Leo I.; Karmali, Reem; Winter, Jane N.; Ma, Shuo; Kaplan, Jason B.; Behdad, Amir; Klein, Andreas; Jovanovic, Borko; Helenowski, Irene; Smith, Sonali M.; Evens, Andrew M.; Pro, Barbara Journal: Leukemia & lymphoma Issue: Volume 62:Issue 14(2021) Page Start: 3493 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Cachexia is a risk factor for negative clinical and functional outcomes in patients receiving chimeric antigen receptor T‐cell therapy for B‐cell non‐Hodgkin lymphoma. (9th February 2022) Authors: Roy, Ishan; Smilnak, Gordon; Burkart, Madelyn; Hamilton, Elizabeth; Thorp, Katherine; Miyata, Sarah; Ma, Shuo; Pro, Barbara; Winter, Jane; Gordon, Leo; Karmali, Reem Journal: British journal of haematology Issue: Volume 197:Number 1(2022) Page Start: 71 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. T time: Emerging and new therapies for peripheral T-cell lymphoma. (March 2022) Authors: Mina, Alain; Pro, Barbara Journal: Blood reviews Issue: Volume 52(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗